Exhibit 107
Calculation of Filing Fee Tables
|
Form S-8 |
(Form Type) |
Terns Pharmaceuticals, Inc. |
(Exact Name of Registrant as Specified in its Charter) |
Table 1—Newly Registered Securities
| | | | | | | | | | | | | | | | |
Security
Type | | Security Class
Title | | Fee
Calculation
Rule | | Amount
Registered
(1) | | Proposed
Maximum
Offering
Price Per
Share (2) | | Maximum
Aggregate
Offering Price | | Fee Rate | | Amount of
Registration
Fee | |
Equity | | Common Stock, $0.0001 par value per share | | 457(c) and 457(h) | | 3,223,389 shares (3) | | | $12.74 | | $41,065,975.86 | | $110.20
per $1,000,000 | | $4,525.47 | |
Total Offering Amounts | | | | | $41,065,975.86 | | | | $4,525.47 | |
Total Fee Offsets | | | | | | | | | — | |
Net Fee Due | | | | | | | | | $4,525.47 | |
| |
(1) | Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of the Registrant’s common stock that becomes issuable under the 2021 Incentive Award Plan (the “2021 Plan”) and the 2021 Employee Stock Purchase Plan (“ESPP”) by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration that increases the number of the Registrant’s outstanding shares of common stock. |
| |
(2) | Pursuant to 457(c) and 457(h) under the Securities Act, the proposed maximum offering price per share is estimated solely for the purpose of calculating the registration fee and is based upon the average of the high and low prices of the Registrant’s common stock as reported on the Nasdaq Global Select Market on May 11, 2023, which date is within five business days prior to filing this Registration Statement. |
| |
(3) | Consists of (i) 2,686,158 additional shares of the Registrant’s common stock that became available for issuance on January 1, 2023 under the 2021 Plan, by operation of an automatic annual increase provision therein, and (ii) 537,231 additional shares of the Registrant’s common stock that became available for issuance on January 1, 2023 under the ESPP, by operation of an automatic annual increase provision therein. |
